Search results
Showing 31 to 45 of 123 results for hepatitis
uptake of hepatitis C treatment be improved? What factors influence whether or not specific groups at increased risk will begin and...
Tenofovir alafenamide for treating chronic hepatitis B (terminated appraisal) (TA435)
NICE was unable to make a recommendation about the use in the NHS of tenofovir alafenamide for treating chronic hepatitis B because no evidence submission was received from Gilead, but will review this decision if the company decides to make a submission.
Show all sections
Sections for TA435
Question Long-term safety of tenofovir disoproxil in chronic hepatitis B:- Further research should be undertaken to determine the...
This guideline covers diagnosing and managing drug allergy in all age groups. It aims to make it easier for professionals to tell when someone is having an allergic reaction, by specifying the key signs and patterns to look out for. It also makes recommendations on improving people’s understanding of their drug allergies, and ensuring these are recorded properly in their medical records.
Evidence-based recommendations on Virtual Touch Quantification to diagnose and monitor liver fibrosis in chronic hepatitis B and C.
and cost effectiveness of hepatitis B surface antigen (HBsAg) quantitative assays in determining treatment duration in...
Rituximab for the treatment of relapsed or refractory chronic lymphocytic leukaemia (TA193)
Evidence-based recommendations on rituximab for treating relapsed or refractory chronic lymphocytic leukaemia in adults.
risk in awareness-raising about, and promoting testing and treatment for, hepatitis B and C infection? Specifically, how cost effective...
ensure continuity of care for prisoners who are diagnosed with chronic hepatitis B or C in prison? Any explanatory notes(if applicable)...
Question How many children in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come...
Question How many people in the UK are infected with chronic hepatitis B and C and which subgroups of the population do they come from?...
Question What impact does increased knowledge and awareness of hepatitis B and C among the general public have on the uptake of testing...
Question What cost-effective interventions can be used to increase hepatitis B case-finding among migrant populations in primary and...
for hepatitis B and C? Any explanatory notes(if applicable) None. Source guidance details Comes from guidance Hepatitis B...
communicable diseases could be used to encourage people at increased risk of hepatitis B and C infection to take up the offer of testing...